In this episode of Paul Talks Science, I speak with Prof. Christian Gilissen, Professor in Genome Bioinformatics and Head of Bioinformatics at Radboud University Medical Center, about the game-changing potential of long-read sequencing in rare disease diagnosis.

We dive into:
🔬 How long-read sequencing works and why it matters
🧬 Its advantages over traditional short-read sequencing
💡 The impact on patient diagnostics and clinical care
💰 The challenges of cost and accessibility
⚖️ Ethical and regulatory considerations

Prof. Gilissen shares insights from his latest research and explains why long-read sequencing could soon become the new standard in genomic medicine.

🎧 Tune in to explore the future of rare disease diagnosis and how cutting-edge science is bringing hope to millions.

📖 Read my article on this topic: "The New Frontier of Genomic Testing for Rare Diseases"

🔔 Follow Paul Talks Science for more deep dives into groundbreaking research, innovations, and the experts shaping the future of medicine.

#Genomics #RareDiseases #LongReadSequencing #GeneticTesting #Bioinformatics #PrecisionMedicine #SciencePodcast #PaulTalksScience